United Therapeutics Corp (UTHR)
378.96
+2.16
(+0.57%)
USD |
NASDAQ |
Nov 05, 11:18
United Therapeutics Market Cap: 16.92B for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 16.82B |
| November 01, 2024 | 16.70B |
| October 31, 2024 | 16.70B |
| October 30, 2024 | 16.13B |
| October 29, 2024 | 15.75B |
| October 28, 2024 | 15.61B |
| October 25, 2024 | 15.57B |
| October 24, 2024 | 15.63B |
| October 23, 2024 | 15.74B |
| October 22, 2024 | 16.52B |
| October 21, 2024 | 16.53B |
| October 18, 2024 | 16.44B |
| October 17, 2024 | 16.63B |
| October 16, 2024 | 16.51B |
| October 15, 2024 | 16.04B |
| October 14, 2024 | 15.93B |
| October 11, 2024 | 15.98B |
| October 10, 2024 | 15.81B |
| October 09, 2024 | 15.92B |
| October 08, 2024 | 15.87B |
| October 07, 2024 | 15.61B |
| October 04, 2024 | 15.88B |
| October 03, 2024 | 15.62B |
| October 02, 2024 | 15.73B |
| October 01, 2024 | 15.96B |
| Date | Value |
|---|---|
| September 30, 2024 | 15.99B |
| September 27, 2024 | 15.95B |
| September 26, 2024 | 15.92B |
| September 25, 2024 | 16.00B |
| September 24, 2024 | 15.92B |
| September 23, 2024 | 15.82B |
| September 20, 2024 | 15.71B |
| September 19, 2024 | 15.63B |
| September 18, 2024 | 15.24B |
| September 17, 2024 | 15.35B |
| September 16, 2024 | 15.35B |
| September 13, 2024 | 15.09B |
| September 12, 2024 | 15.18B |
| September 11, 2024 | 15.40B |
| September 10, 2024 | 15.24B |
| September 09, 2024 | 15.51B |
| September 06, 2024 | 15.38B |
| September 05, 2024 | 15.57B |
| September 04, 2024 | 15.72B |
| September 03, 2024 | 15.68B |
| August 30, 2024 | 16.17B |
| August 29, 2024 | 16.03B |
| August 28, 2024 | 16.01B |
| August 27, 2024 | 15.54B |
| August 26, 2024 | 15.42B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.484B
Minimum
Mar 18 2020
16.92B
Maximum
Nov 05 2024
9.127B
Average
9.457B
Median
Sep 08 2021
Market Cap Benchmarks
| Liquidia Corp | 866.56M |
| Pfizer Inc | 157.48B |
| Tonix Pharmaceuticals Holding Corp | 3.081M |
| Ardelyx Inc | 1.370B |
| Entrada Therapeutics Inc | 663.64M |
Market Cap Related Metrics
| PE Ratio | 16.64 |
| PS Ratio | 6.723 |
| PEG Ratio | 0.6538 |
| Price to Book Value | 2.773 |
| Price to Free Cash Flow | 20.63 |
| Price | 378.96 |
| Earnings Yield | 6.01% |
| PEGY Ratio | 0.6538 |
| Operating PE Ratio | 13.78 |
| Normalized PE Ratio | 15.90 |